BR100 Decreased By (-0.08%)
BR30 Increased By (0%)
KSE100 Increased By (0.09%)
KSE30 Increased By (0.07%)
AGHA 6.49 Increased By ▲ 0.17 (2.69%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.10 Decreased By ▼ -0.35 (-0.56%)
BOP 31.30 Increased By ▲ 0.07 (0.22%)
CNERGY 11.74 Increased By ▲ 0.15 (1.29%)
CSIL 6.00 Increased By ▲ 0.28 (4.9%)
FCCL 60.80 Decreased By ▼ -0.74 (-1.2%)
FFL 14.90 Decreased By ▼ -0.12 (-0.8%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.28 Increased By ▲ 0.02 (0.32%)
KOSM 5.74 Increased By ▲ 0.18 (3.24%)
LOTCHEM 24.78 Increased By ▲ 0.10 (0.41%)
MLCF 103.12 Decreased By ▼ -0.96 (-0.92%)
NBP 174.73 Decreased By ▼ -0.55 (-0.31%)
NCPL 52.97 Increased By ▲ 0.20 (0.38%)
NPL 54.60 Increased By ▲ 0.48 (0.89%)
OGDC 313.75 Increased By ▲ 0.36 (0.11%)
PACE 9.25 Increased By ▲ 0.05 (0.54%)
PAEL 35.50 Decreased By ▼ -0.30 (-0.84%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 221.11 Decreased By ▼ -0.70 (-0.32%)
PRL 80.88 Increased By ▲ 1.80 (2.28%)
PTC 46.97 Increased By ▲ 0.12 (0.26%)
SSGC 24.10 Increased By ▲ 0.23 (0.96%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.44 Increased By ▲ 0.05 (0.68%)
TPL 24.87 Decreased By ▼ -0.24 (-0.96%)
TPLP 12.90 Increased By ▲ 0.39 (3.12%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.97 Increased By ▲ 0.53 (0.99%)
World

Putin declines British invitation to take part in coronavirus summit

  • Putin received an invitation to take part in the summit from British Prime Minister Boris Johnson last week, the Kremlin had said.
Published Updated
By

MOSCOW: Russian President Vladimir Putin does not plan to take part in an online summit on a possible coronavirus vaccine being organised by the British government this week, Kremlin spokesman Dmitry Peskov said on Wednesday.

Putin received an invitation to take part in the summit from British Prime Minister Boris Johnson last week, the Kremlin had said.

Scheduled to take place on June 4, the Global Vaccine Summit 2020 is designed to mobilise resources needed to ensure universal availability of the vaccine against the novel coronavirus.

Comments

Comments are closed for this article.